Scholarlink

<p>Worldwide, chronic kidney disease (CKD) is a systemic healthcare burden, necessitating continuous innovation in diagnostic and therapeutic strategies. Henceforth, many research endeavors have been pursued to develop point-of-care (POC) technologies aimed at recognizing CKD biomarkers. This research put forwards a comprehensive overview of recent advances in patentable technologies designed specifically to diagnose and treat CKD. Specifically, this review explores cutting-edge biomarkers, imaging techniques, and POC testing methods that enable early and accurate CKD detection. This exploration highlights the intersection of diagnostic innovation and intellectual property, focusing on patentable technologies that are reshaping CKD management. The paper discusses the implications of patent protection on fostering research and development, encouraging investment in CKD technologies, and ultimately improving patient outcomes. The analysis expands to cover the contemporary challenges for the technological advancement towards the early diagnosis and treatment of CKD. By integrating insights from recent patent filings, this review disseminates relevant and state-of-the art information for the evolving landscape of CKD diagnosis and treatment, guiding researchers, healthcare professionals, and policymakers toward future advancements in kidney healthcare.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Recent advancements in patented technologies for the diagnosis and treatment of chronic kidney disease

  • 期刊论文

  • 发表日期：

    2025年4月11日

查看全文
  • Poornima Bhatt,
  • Monika Chhillar,
  • Akshit Kumar,
  • Deepak Kukkar,
  • Manil Kukkar

摘要

Worldwide, chronic kidney disease (CKD) is a systemic healthcare burden, necessitating continuous innovation in diagnostic and therapeutic strategies. Henceforth, many research endeavors have been pursued to develop point-of-care (POC) technologies aimed at recognizing CKD biomarkers. This research put forwards a comprehensive overview of recent advances in patentable technologies designed specifically to diagnose and treat CKD. Specifically, this review explores cutting-edge biomarkers, imaging techniques, and POC testing methods that enable early and accurate CKD detection. This exploration highlights the intersection of diagnostic innovation and intellectual property, focusing on patentable technologies that are reshaping CKD management. The paper discusses the implications of patent protection on fostering research and development, encouraging investment in CKD technologies, and ultimately improving patient outcomes. The analysis expands to cover the contemporary challenges for the technological advancement towards the early diagnosis and treatment of CKD. By integrating insights from recent patent filings, this review disseminates relevant and state-of-the art information for the evolving landscape of CKD diagnosis and treatment, guiding researchers, healthcare professionals, and policymakers toward future advancements in kidney healthcare.